The Executive Compensation Advisor Blog

The Pearl Meyer Advisor Blog provides the latest information and insight from our senior consultants on compensation trends and issues.

Browse by Date

Posted By

Terry Newth

Joe McNeal

Aug 9, 2022

Biotech Layoffs: Ideas for Creating a Fair Compensation Plan

When considering staffing reductions, a fair and empathetic compensation program is imperative in the tight-knit biotech and pharma industries.

Posted By

David Swinford

Jul 27, 2022

Leading an Effective CEO Transition: It’s a Journey, Not an Event

Leadership transition is an ongoing process. Here are four guiding points for boards and CEOs to consider as they plan.

Posted By

Matt Molberger

Jul 5, 2022

Option Repricing or Exchanges in Development Biotech

For biotech, the retention value of options is currently in jeopardy. Here are several key points to weigh if your company is considering strong action.

Posted By

Simon Patterson

Jun 9, 2022

How Companies in the UK are Thinking About Equity Today

Similar to what is happening in the US, UK companies are using equity as one way to combat the talent shortage.

Posted By

Jim Hudner

Jun 1, 2022

An Argument for Getting The Healthcare Board Involved in Broad-Based Compensation Issues

A changing talent landscape and numerous external influences may require the board to look closer at workforce pay.

1
2
3
4
5
6
7
8
9
…
next ›
last »

The Executive Compensation Advisor Blog

Browse by Date

Biotech Layoffs: Ideas for Creating a Fair Compensation Plan

Leading an Effective CEO Transition: It’s a Journey, Not an Event

Option Repricing or Exchanges in Development Biotech

How Companies in the UK are Thinking About Equity Today

An Argument for Getting The Healthcare Board Involved in Broad-Based Compensation Issues

Pages